As per MRFR analysis, the South Korea Kidney Stones Market Size was estimated at 52 (USD Million) in 2023. The South Korea Kidney Stones Market Industry is expected to grow from 54 (USD Million) in 2024 to 160 (USD Million) by 2035.The South Korea Kidney Stones Market CAGR (growth rate) is expected to be around 10.378% during the forecast period (2025 - 2035).
The South Korea Kidney Stones Market is undergoing notable shifts stemming from the increased awareness of kidney health among the populace. The rising prevalence of kidney stones in South Korea due to dietary and lifestyle changes has created a demand for effective treatments and preventive measures.
This demand is also backed by government programs that seek to raise health awareness and encourage healthier eating habits to reduce the risk of stone development. The increasing rates of obesity and metabolic syndrome in this region, which are known to be associated with kidney stones, also serve as important market contributors.
With a greater emphasis on preventative care by healthcare professionals, interest in diet therapy programs and stone analysis services is on the rise. Technological innovations in the field of diagnostic imaging and other laparoscopic surgery procedures are also improving patient treatment options, which is essential for those seeking rapid recovery and shorter hospital stays.
There is room within the South Korean market for the creation of kidney health specific products such as supplements, beverages, and hydration solutions intended for stone prevention. These product offerings could be strengthened through partnerships with local healthcare providers.
Trends show growth in the utilization of mobile health applications that educate patients on self-management and prevention of kidney stones. Stakeholders in the South Korea Kidney Stones Market can improve overall patient outcomes and quality of care by addressing these new opportunities and market needs.
The South Korea Kidney Stones Market Industry is experiencing significant growth due to the increasing incidence of kidney stones among the population. According to a study conducted by the Korean Urological Association, the prevalence of kidney stones in South Korea has surged over the past decade, with a reported 70% increase in cases from 2010 to 2020.
This alarming trend indicates that nearly 1 in 10 South Koreans will develop kidney stones in their lifetime, highlighting the urgency for effective treatment solutions. Established organizations like the Korean Society of Nephrology have been actively involved in raising awareness and providing education about kidney stones, contributing to early diagnosis and treatment, which in turn fuels the growth of the kidney stones market in the region.
As healthcare providers continue to address this growing health issue, investment in better medical technologies and treatments is expected to drive market expansion significantly.
The South Korea Kidney Stones Market Industry is poised for substantial growth due to rapid advancements in medical technology. Innovations in laser lithotripsy and minimally invasive surgical techniques are facilitating better patient outcomes. According to the Ministry of Health and Welfare in South Korea, the number of procedures performed using advanced technologies has increased by over 50% in the last five years.
This shift has not only improved recovery times but has also led to an increase in the number of patients seeking treatment for kidney stones. Major hospitals in South Korea, such as Seoul National University Hospital, are at the forefront of implementing these advanced procedures, thereby enhancing the overall market landscape.
In the South Korea Kidney Stones Market Industry, the emphasis on preventive healthcare is driving market growth. Recent initiatives by the South Korean government to promote health awareness are pivotal in educating the public on kidney stone prevention through dietary changes and lifestyle modifications.
According to recent reports from the Korean Nutrition Society, there has been a 30% rise in public workshops and seminars focused on preventive measures against kidney stones. The increase in health literacy among the population, supported by government campaigns, is resulting in earlier intervention, which further stimulates the demand for kidney stone treatments and related services.
The South Korea Kidney Stones Market segmentation by Type reveals significant insights into the prevalence and treatment options available for various kinds of kidney stones affecting the population. Among these types, Calcium Oxalate Stones due to their high formation rates in the south of Korea account for a majority holding in the market, often attributed to dietary habits heavy in oxalate-rich foods.
Uric Acid stones, while less common, are seeing a rise in prevalence, particularly among individuals with metabolic syndromes, presenting opportunities for targeted treatment and prevention strategies. Struvite Kidney Stones, which often arise as a result of urinary tract infections, reflect a different set of challenges in healthcare management, as they require both addressing the stones and the underlying infections.
Cystine Stones, although less frequently encountered, predominantly affect those with the rare genetic disorder cystinuria and bring forth the need for specialized medical interventions and robust patient education regarding hydration and dietary modifications. Lastly, Calcium Phosphate Stones are often associated with certain metabolic disorders and are becoming increasingly significant as awareness grows regarding associated health conditions, leading to proactive healthcare measures.
As the South Korea Kidney Stones Market continues to evolve, understanding these segments not only aids in addressing patient care but also emphasizes the need for tailored prevention and educational programs to potentially reduce incidences across the varying types of kidney stones.
The South Korea Kidney Stones Market is witnessing significant advancements in treatment options classified under the Treatment Type segment. This market encompasses various methods including Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithotomy, each playing a crucial role in managing kidney stones effectively.
Medications are essential for pain relief and preventing stone formation, catering to a large patient population who prefer non-invasive approaches. Extracorporeal Shock Wave Lithotripsy stands out as a popular non-invasive option that utilizes shock waves to fragment stones, thus minimizing recovery time and hospital stays, reflecting the increasing preference for outpatient therapies.
Ureteroscopy offers direct access to stones within the urinary tract and is particularly beneficial for larger stones, allowing for immediate removal which is vital in urgent cases. Lastly, Percutaneous Nephrolithotomy is often reserved for complex or large stone cases, and it signifies a critical intervention in advanced scenarios.
As kidney stone prevalence rises in South Korea owing to lifestyle changes, each of these treatment methods showcases unique advantages, driving growth within the South Korea Kidney Stones Market and enhancing patient outcomes in a region increasingly focused on effective renal healthcare solutions.
The Diagnosis segment of the South Korea Kidney Stones Market demonstrates significant growth potential, largely driven by the rising prevalence of kidney stones among the population. With advanced healthcare infrastructure and increasing awareness among patients, diagnostic methods such as Ultrasound and CT scans have gained notable adoption in clinical settings.
Ultrasound is particularly valued for its non-invasive nature and lack of radiation exposure, making it a preferred choice for initial assessments. Meanwhile, Intravenous Pyelography offers detailed imaging, which enhances the accuracy of diagnoses, thereby boosting the overall efficacy of treatment strategies.
CT scans are regarded as particularly important for their ability to provide high-resolution images that assist in identifying stone composition and location. X-Ray remains a basic yet essential tool in diagnosis for some cases, showcasing its integral role in the diagnostic process.
The growing focus on early diagnosis and timely treatment interventions in South Korea further elevates the importance of these diagnostic methods, suggesting a robust future for the segment. Moreover, the strong support from government health initiatives aimed at reducing kidney stone incidences reinforces the evolution of the South Korea Kidney Stones Market, creating opportunities for technological advancements in diagnostic tools.
Overall, this segment exhibits a promising landscape characterized by innovation and increased healthcare expenditure, positioning it as a critical component of kidney stone management in South Korea.
The South Korea Kidney Stones Market is a dynamic arena characterized by heightened competition among various entities focused on the prevention, identification, and treatment of kidney-related ailments. The rise in lifestyle diseases, coupled with unhealthy dietary habits, has led to an increasing prevalence of kidney stones in the region, creating a robust demand for innovative solutions and therapies.
Companies are actively engaged in research and development efforts to enhance treatment options, which include medical management, surgical interventions, and minimally invasive procedures. As healthcare systems evolve, the interplay between healthcare providers, pharmaceutical companies, and medical device manufacturers plays a crucial role in shaping market strategies and operational effectiveness, thereby influencing patient outcomes and market dynamics.
Gachon University holds a significant position in the South Korea Kidney Stones Market, primarily recognized for its advanced medical research and educational contributions. As an educational institution, Gachon University emphasizes a multidisciplinary approach to healthcare, fostering a collaborative environment for researchers and healthcare practitioners to develop novel treatment methodologies.
Its strengths lie in specializing in urology and nephrology, where faculty members are engaged in cutting-edge research related to kidney stones. Furthermore, Gachon University has established partnerships with various healthcare organizations, which enhances its clinical exposure and improves patient care dynamics in the realm of kidney stone management, thereby further solidifying its reputation and impact within the South Korean healthcare landscape.
Hanmi Pharmaceutical is well-positioned within the South Korea Kidney Stones Market, known for its dedication to pharmaceutical innovations aimed at urological conditions. The company offers a range of products that facilitate the treatment and prevention of kidney stones, demonstrating a commitment to improving patient quality of life.
With a strong market presence in South Korea, Hanmi Pharmaceutical's strengths lie in its extensive research and development capabilities, which are evident in its pipeline of proprietary medications designed specifically for kidney stone management. The company has pursued strategic mergers and acquisitions to bolster its operational efficiencies and expand its portfolio, allowing for enhanced service offerings in urology-focused therapies.
These initiatives reflect Hanmi Pharmaceutical’s proactive approach to maintain its competitive edge and cater to the evolving needs of healthcare professionals and patients dealing with kidney stone issues.
Recent developments in the South Korea Kidney Stones Market have seen significant advancements, particularly in the integration of innovative health technologies and research initiatives. For instance, Gachon University and Korea University Anam Hospital have been collaborating on cutting-edge research focused on enhancing diagnostic methodologies for kidney stones.
Additionally, Hanmi Pharmaceutical is actively engaging in the development of medications aimed at reducing the recurrence of kidney stones. Severance Hospital and Samsung Medison are also investing in advanced imaging techniques to diagnose and treat kidney stones more effectively.
Regarding mergers and acquisitions, notable activities included a partnership between Asan Medical Center and DongA ST in July 2023 to enhance their urology treatment capabilities through combined research efforts. Over the past two to three years, the market has experienced substantial growth, with LG Chem and Daewoong Pharmaceutical both reporting expansion in their product lines related to kidney health, illustrating a broader trend towards preventative healthcare solutions.
The Korean government has emphasized the importance of addressing kidney stone prevalence with new health policies aimed at improving diagnostic and treatment facilities nationwide.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 52.0(USD Million) |
| MARKET SIZE 2024 | 54.0(USD Million) |
| MARKET SIZE 2035 | 160.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.378% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Gachon University, Hanmi Pharmaceutical, Severance Hospital, Sungkyunkwan University, Busan National University, Samsung Medison, DongA ST, Korea Institute of Radiological & Medical Sciences, NMC Healthcare, Kyungpook National University, Korea University Anam Hospital, LG Chem, Daewoong Pharmaceutical, Asan Medical Center, Chungbuk National University |
| SEGMENTS COVERED | Type, Treatment Type, Diagnosis |
| KEY MARKET OPPORTUNITIES | Rising prevalence of kidney stones, Advanced treatment technologies adoption, Increased health awareness campaigns, Aging population with healthcare needs, Expansion of telehealth services |
| KEY MARKET DYNAMICS | increasing prevalence of kidney stones, growing awareness of treatment options, advancements in medical technology, rising healthcare expenditures, demand for minimally invasive procedures |
| COUNTRIES COVERED | South Korea |
Frequently Asked Questions (FAQ) :
The South Korea Kidney Stones Market is expected to be valued at 54.0 USD Million in 2024.
The market is anticipated to reach a value of 160.0 USD Million in 2035.
The expected CAGR for the South Korea Kidney Stones Market during this period is 10.378 %.
Calcium Oxalate Stones are expected to dominate the market with a value of 21.0 USD Million in 2024.
The market size for Uric Acid stones is expected to reach 35.9 USD Million by 2035.
Major players in the market include Gachon University, Hanmi Pharmaceutical, and Samsung Medison.
In 2024, the market for Struvite Kidney Stones is valued at 8.0 USD Million.
There are opportunities for growth driven by advances in medical treatments and increasing awareness about kidney stone management.
The expected market size for Cystine Stones by 2035 is 18.0 USD Million.
The market is projected to witness significant growth across all segments, with Calcium Phosphate Stones expected to reach 19.3 USD Million in 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
